[Proceedings: Detection of renin-angiotensin-aldosterone system in idiopathic edema]. 1974

T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara
December 1969, Klinische Wochenschrift,
T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara
June 2004, Nihon rinsho. Japanese journal of clinical medicine,
T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara
July 1980, European journal of clinical pharmacology,
T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara
April 2007, Nihon rinsho. Japanese journal of clinical medicine,
T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara
January 1975, Naunyn-Schmiedeberg's archives of pharmacology,
T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara
February 1979, Archives internationales de physiologie et de biochimie,
T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara
February 1981, Nihon rinsho. Japanese journal of clinical medicine,
T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara
November 1977, Deutsche medizinische Wochenschrift (1946),
T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara
May 2024, Pflugers Archiv : European journal of physiology,
T Yamamoto, and H Doi, and K Omori, and T Ogihara, and Y Kumahara
September 1969, Kardiologiia,
Copied contents to your clipboard!